Skip to content
news
About TTIC
Introduction
Organization
Contact us
Location
Innovation& Incubation center
Introduction
Application Procedure
News
Intellectual property management & Technology transfer
Introduction
News
Industry-academia collaboration planning
Introduction
Exhibition activities
Download
Related sites
Contact Us
Gnex
Biomodel& tec. avatar medicine
繁體中文
Menu
news
About TTIC
Introduction
Organization
Contact us
Location
Innovation& Incubation center
Introduction
Application Procedure
News
Intellectual property management & Technology transfer
Introduction
News
Industry-academia collaboration planning
Introduction
Exhibition activities
Download
Related sites
Contact Us
Gnex
Biomodel& tec. avatar medicine
繁體中文
news
About TTIC
Introduction
Organization
Contact us
Location
Innovation& Incubation center
Introduction
Application Procedure
News
Intellectual property management & Technology transfer
Introduction
News
Industry-academia collaboration planning
Introduction
Exhibition activities
Download
Related sites
Contact Us
Gnex
Biomodel& tec. avatar medicine
繁體中文
Menu
news
About TTIC
Introduction
Organization
Contact us
Location
Innovation& Incubation center
Introduction
Application Procedure
News
Intellectual property management & Technology transfer
Introduction
News
Industry-academia collaboration planning
Introduction
Exhibition activities
Download
Related sites
Contact Us
Gnex
Biomodel& tec. avatar medicine
繁體中文
MAP4K3 is a therapeutic target for cancer and IL-17A-mediated autoimmune disease
Prev
Previous
Targeted antigen delivery system
Next
本院「小分子藥物複合體Small Molecule Drug Conjugates」計畫公開徵求產學合作廠商（2019/05/22）
Next
